A detailed history of Forvis Wealth Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Forvis Wealth Advisors, LLC holds 55,356 shares of MRK stock, worth $5.49 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
55,356
Previous 56,986 2.86%
Holding current value
$5.49 Million
Previous $7.05 Million 10.89%
% of portfolio
0.15%
Previous 0.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $181,174 - $210,221
-1,630 Reduced 2.86%
55,356 $6.29 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $284,492 - $305,542
2,298 Added 4.2%
56,986 $7.05 Million
Q1 2024

Apr 19, 2024

SELL
$113.24 - $131.95 $390,338 - $454,831
-3,447 Reduced 5.93%
54,688 $7.22 Million
Q4 2023

Jan 11, 2024

SELL
$100.18 - $109.02 $277,999 - $302,530
-2,775 Reduced 4.56%
58,135 $6.34 Million
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $1.83 Million - $2.04 Million
-17,808 Reduced 22.62%
60,910 $6.27 Million
Q2 2023

Aug 08, 2023

BUY
$108.61 - $118.38 $1.96 Million - $2.13 Million
18,024 Added 29.7%
78,718 $9.08 Million
Q1 2023

Apr 26, 2023

BUY
$102.94 - $114.86 $230,276 - $256,941
2,237 Added 3.83%
60,694 $6.46 Million
Q4 2022

Feb 02, 2023

SELL
$87.44 - $112.11 $107,551 - $137,895
-1,230 Reduced 2.06%
58,457 $6.48 Million
Q3 2022

Oct 13, 2022

BUY
$84.53 - $94.96 $129,753 - $145,763
1,535 Added 2.64%
59,687 $5.14 Million
Q2 2022

Jul 22, 2022

BUY
$83.49 - $94.64 $1.48 Million - $1.67 Million
17,677 Added 43.67%
58,152 $5.3 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $244,200 - $273,732
3,322 Added 8.94%
40,475 $3.32 Million
Q4 2021

Jan 14, 2022

BUY
$72.28 - $90.54 $111,961 - $140,246
1,549 Added 4.35%
37,153 $2.85 Million
Q3 2021

Oct 14, 2021

BUY
$71.68 - $78.83 $61,214 - $67,320
854 Added 2.46%
35,604 $2.67 Million
Q2 2021

Jul 14, 2021

SELL
$70.31 - $77.77 $60,115 - $66,493
-855 Reduced 2.4%
34,750 $2.7 Million
Q1 2021

Apr 23, 2021

SELL
$68.86 - $81.11 $646,664 - $761,704
-9,391 Reduced 20.87%
35,605 $2.75 Million
Q4 2020

Jan 22, 2021

BUY
$71.77 - $79.65 $192,200 - $213,302
2,678 Added 6.33%
44,996 $3.68 Million
Q3 2020

Nov 05, 2020

BUY
$73.18 - $82.95 $76,180 - $86,350
1,041 Added 2.52%
42,318 $3.51 Million
Q2 2020

Jul 15, 2020

BUY
$70.42 - $80.13 $378,155 - $430,298
5,370 Added 14.96%
41,277 $3.19 Million
Q1 2020

Apr 10, 2020

BUY
$63.36 - $87.82 $296,778 - $411,348
4,684 Added 15.0%
35,907 $2.76 Million
Q4 2019

Jan 13, 2020

BUY
$77.58 - $87.54 $81,303 - $91,741
1,048 Added 3.47%
31,223 $2.84 Million
Q3 2019

Oct 29, 2019

SELL
$76.08 - $82.93 $50,745 - $55,314
-667 Reduced 2.16%
30,175 $2.54 Million
Q2 2019

Jul 10, 2019

SELL
$69.84 - $81.59 $110,836 - $129,483
-1,587 Reduced 4.89%
30,842 $2.59 Million
Q1 2019

Apr 10, 2019

BUY
$69.58 - $79.36 $1.07 Million - $1.22 Million
15,326 Added 89.61%
32,429 $2.7 Million
Q4 2018

Jan 15, 2019

SELL
$65.24 - $75.71 $720,445 - $836,065
-11,043 Reduced 39.23%
17,103 $1.31 Million
Q3 2018

Oct 09, 2018

BUY
$57.69 - $67.84 $115,380 - $135,680
2,000 Added 7.65%
28,146 $2 Million
Q2 2018

Jul 13, 2018

BUY
$50.83 - $59.72 $34,106 - $40,072
671 Added 2.63%
26,146 $1.59 Million
Q1 2018

May 25, 2018

BUY
$50.96 - $59.23 $1,426 - $1,658
28 Added 0.11%
25,475 $1.39 Million
Q1 2018

Apr 20, 2018

BUY
$50.96 - $59.23 $491,967 - $571,806
9,654 Added 61.13%
25,447 $1.5 Million
Q4 2017

Jan 18, 2018

SELL
$51.62 - $61.64 $198,788 - $237,375
-3,851 Reduced 19.6%
15,793 $889,000
Q3 2017

Oct 13, 2017

BUY
$58.67 - $63.13 $1.15 Million - $1.24 Million
19,644
19,644 $1.26 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Forvis Wealth Advisors, LLC Portfolio

Follow Forvis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forvis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forvis Wealth Advisors, LLC with notifications on news.